The goal of this research is to determine whether benfotiamine, a synthetic version of thiamine or vitamin B1, is a treatment for mild cognitive impairment or early Alzheimer’s Disease.

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in early diagnosis for the disease affecting millions.

For many years, astrocytes were seen as simple support cells in the brain. Today, that picture is changing fast.

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by ...

Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the ...

A major global study tested whether European-derived polygenic risk scores (PGS) for Alzheimer’s disease can predict risk ...

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. | ITV National News ...

NICE decided that two Alzheimer’s drugs are too expensive for their modest benefits and cannot be recommended for NHS use in ...

One of the most common genes associated with Alzheimer's has now been linked to loss of smell. The discovery may offer a new ...

But in a surprise twist, recent research published by my colleagues and me has found that a protein from Helicobacter pylori ...